Literature DB >> 17077686

The epidemiology of acute renal failure: 1975 versus 2005.

Rinaldo Bellomo1.   

Abstract

PURPOSE OF REVIEW: Data from the mid 1970s relating to the clinical features, pathogenesis, treatment and outcome of patients affected by acute renal failure were compared with data reported in the literature in 2005. RECENT
FINDINGS: The differences in patient characteristics over the last 30 years are profound and claims that the outcome of acute renal failure has not changed over time are equally misleading. Thirty years later patients are older, have more comorbidities, develop renal failure in association with interventions (liver transplantation, lung transplantation, heart and lung transplantation) that essentially did not exist in the 1970s, are sicker with more complex symptoms, receive more effective therapies and survive at higher rates once outcome is adjusted for illness severity.
SUMMARY: The treatment of critically ill patients with acute renal failure has changed dramatically over the last 30 years. As treatment has increased in efficacy and sophistication, so has the severity of the condition.

Entities:  

Mesh:

Year:  2006        PMID: 17077686     DOI: 10.1097/01.ccx.0000247443.86628.68

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  20 in total

1.  Molecular pathology of acute kidney injury in a choline-deficient model and fish oil protective effect.

Authors:  Valeria Denninghoff; Georgina Ossani; Ana Uceda; Matias Rugnone; Elmer Fernández; Cristóbal Fresno; German González; Maria Luisa Díaz; Alejandra Avagnina; Boris Elsner; Alberto Monserrat
Journal:  Eur J Nutr       Date:  2013-10-16       Impact factor: 5.614

Review 2.  [New KDIGO guidelines on acute kidney injury. Practical recommendations].

Authors:  A Zarbock; S John; A Jörres; D Kindgen-Milles
Journal:  Anaesthesist       Date:  2014-07       Impact factor: 1.041

Review 3.  Acute kidney injury-epidemiology, outcomes and economics.

Authors:  Oleksa Rewa; Sean M Bagshaw
Journal:  Nat Rev Nephrol       Date:  2014-01-21       Impact factor: 28.314

Review 4.  Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury.

Authors:  Prasad Devarajan
Journal:  Biomark Med       Date:  2010-04       Impact factor: 2.851

5.  Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia/reperfusion.

Authors:  Ana P Bastos; Klaus Piontek; Ana M Silva; Dino Martini; Luis F Menezes; Jonathan M Fonseca; Ivone I Fonseca; Gregory G Germino; Luiz F Onuchic
Journal:  J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 10.121

6.  Acute kidney injury predicts outcomes of non-critically ill patients.

Authors:  Fidel Barrantes; Yan Feng; Oleg Ivanov; Hima B Yalamanchili; Janki Patel; Xander Buenafe; Vicky Cheng; Sylvester Dijeh; Yaw Amoateng-Adjepong; Constantine A Manthous
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

7.  RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients.

Authors:  Chang-Chyi Jenq; Ming-Hung Tsai; Ya-Chung Tian; Chan-Yu Lin; Chun Yang; Nai-Jen Liu; Jau-Min Lien; Yung-Chang Chen; Ji-Tseng Fang; Pan-Chi Chen; Chih-Wei Yang
Journal:  Intensive Care Med       Date:  2007-06-30       Impact factor: 17.440

8.  Community prescribing of potentially nephrotoxic drugs and risk of acute kidney injury requiring renal replacement therapy in critically ill adults: A national cohort study.

Authors:  Steven Tominey; Alan Timmins; Robert Lee; Timothy S Walsh; Nazir I Lone
Journal:  J Intensive Care Soc       Date:  2020-02-13

Review 9.  Year in review 2007: Critical Care--nephrology.

Authors:  Zaccaria Ricci; Claudio Ronco
Journal:  Crit Care       Date:  2008-10-14       Impact factor: 9.097

10.  Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units.

Authors:  Sean M Bagshaw; Carol George; Rinaldo Bellomo
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.